Limbex

Manufacturer
Energique, Inc. | Apotheca Company
Effective date
2020-06-22
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 23:21:00

Label at a glance#

ProductLimbex
Active ingredientALOE, APIS MELLIFERA, SUS SCROFA CEREBRUM, SUS SCROFA PINEAL GLAND, SUS SCROFA PITUITARY GLAND, SUS SCROFA HYPOTHALAMUS, APIOLE (PARSLEY)
Label structure9 sections

Dosage and administration

Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist, consult your health care professional. Consult a physician for use in children under 12 years of age.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS:

OTC - ACTIVE INGREDIENT SECTION

Aloe 3X, 6X, 12X, 30X, 60X, 100X, 200X, Apis Mellifica 3X, 6X, 30X, 60X, 100X, 200X, Cerebrum Suis 6X, 12X, 30X, 60X, 100X, 200X, Pineal Gland (Suis) 6X, 12X, 30X, 60X, 100X, 200X, Pituitaria Glandula (Suis) 6X, 12X, 30X, 60X, 100X, 200X, Hypothalamus (Suis) 8X, 12X, 30X, 60X, 100X, 200X, Apiolum 12X, 30X, 60X, 100X, 200X.

INDICATIONS:

OTC - PURPOSE SECTION

May temporarily relieve symptoms related to the limbic system such as fear, melancholy and poor memory.**

**These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

WARNINGS:

WARNINGS SECTION

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.

KEEP OUT OF REACH OF CHILDREN:

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist, consult your health care professional. Consult a physician for use in children under 12 years of age.

INDICATIONS:

INDICATIONS & USAGE SECTION

May temporarily relieve symptoms related to the limbic system such as fear, melancholy and poor memory.**

**These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

INACTIVE INGREDIENTS:

INACTIVE INGREDIENT SECTION

Demineralized water, 20% Ethanol

QUESTIONS:

OTC - QUESTIONS SECTION

Dist. by Energique, Inc.

201 Apple Blvd

Woodbine, IA 51579   800-869-8078

PACKAGE LABEL DISPLAY:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ENERGIQUE

SINCE 1987

HOMEOPATHIC REMEDY

LIMBEX

1 fl. oz. (30 ml)

LimbexLimbex

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
44911-0321-12020-07-18C16284748780-19d75b9cf-fc1a-f424-e053-dadaa90a57ceDrug Facts:
44911-0321-12020-01-31C16284748780-19d75b9cf-fc1a-f424-e053-dadaa90a57ceDrug Facts:

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
44911-032144911-0321-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
f50a1819-b044-42fe-ab22-bdbaddd73a674d072d1b-ca23-49f8-b852-6e136e7a56412020-06-22WarningsExact identifier
spl id: f50a1819-b044-42fe-ab22-bdbaddd73a67
spl set id: 4d072d1b-ca23-49f8-b852-6e136e7a5641

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.